Empagliflozin vs Levodopa

Empagliflozin vs Levodopa: Overview

This comparison examines the pharmacological differences between Empagliflozin and Levodopa.

Mechanism of Action

Empagliflozin: Selective SGLT2 inhibitor reducing renal glucose reabsorption.

Levodopa: Metabolic precursor of dopamine that crosses the BBB.

Pharmacokinetics

Half-life: Empagliflozin — 12.4 hours; Levodopa — 1.5 hours.

Chemical Properties

Molecular Formula: Empagliflozin — C23H27ClO7; Levodopa — C9H11NO4.

Molecular Weight: Empagliflozin — 450.9100 g/mol; Levodopa — 197.1880 g/mol.

Type: Empagliflozin — Small molecule; Levodopa — Small molecule.